USPTO serial 86905390
RX ALTONA
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- KUNG, KAELIE ELIZABETH
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RX ALTONA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Crumlin, County Antrim, GB
Crumlin, County Antrim, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Douglas N. Masters
DOUGLAS N. MASTERS LOEB & LOEB LLP321 N. CLARK STREET, SUITE 2300CHICAGO, IL 60654UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; chemical preparations for use in photography; chemicals used in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; chemical reagents for non-medical purposes; enzymes and proteins for scientific and research purposes; diagnostic preparations for scientific purposes; kits comprised primarily of diagnostic preparations for analysis of food products and water for scientific and research use; diagnostic preparations and reagents for clinical use; diagnostic scanning reagents for scientific use; diagnostic preparations for medical laboratory testing | ABANDONED | — |
| 005 | Pharmaceutical, veterinary preparations and substances for the treatment of cancer, immune and autoimmune diseases, cardiac diseases, metabolic and endocrine disorders, blood disorders including coagulation, transmissible agents, therapeutic drug monitoring and identification of drugs of abuse; sanitary preparations for medical use; antitoxic sera and pharmaceutical preparations in the nature of antisera for the treatment of cancer, immune and autoimmune diseases, cardiac diseases, metabolic and endocrine disorders, blood disorders including coagulation, transmissible agents, therapeutic drug monitoring and identification of drugs of abuse; diagnostic preparations for medical purposes; kits comprised of diagnostic preparations for medical purposes; diagnostic scanning agents for medical purposes; clinical diagnostic preparations for medial and veterinary use; diagnostic testing preparations for medical and veterinary use; reagents for use in diagnostic tests for medical and veterinary purposes; reagents for use with analyzers for medical and veterinary purposes | ABANDONED | — |
| 009 | Computer software, none for use in connection with radiation treatment, for use in conjunction with diagnostic testing apparatus, namely, software to control sample handling, sample processing, sample result reporting and test apparatus system robotics; diagnostic apparatus and instruments, not for medical purposes, namely, diagnostic apparatus for the detection of pathogens for laboratory or research use and apparatus for immunoassay procedures, namely, the measurement of antibodies, immunoglobulins, hormones and drugs; diagnostic testing apparatus and instruments for the testing of clinical chemistry for use in immunoassay procedures, not for medical purposes; diagnostic imaging apparatus for use in immunoassay procedures and the study of chemical compounds and structures other than for medical use; clinical laboratory analytical instruments other than for medical use, namely, clinical chemistry or immunoassay analyzers | ABANDONED | — |
| 010 | Medical apparatus and instruments for use in biomarker diagnostics; diagnostic apparatus and instruments for medical use, namely, biomarkers for detecting and analyzing infectious and non-infectious diseases, organ function in humans and animals, therapeutic drugs and drugs of abuse, proteins, acids and antioxidants; electromagnetic diagnostic imaging apparatus for medical use; clinical chemistry analyzers for use in analyzing biological samples for medical and veterinary use; diagnostic testing apparatus and instruments for detection of proteins use in immunoassay procedures; haematology analyzers for medical diagnostic use; clinical laboratory analytical instruments for medical and veterinary use, namely, apparatus for clinical diagnosis in the field of biomarkers | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Randox Laboratories Limited
- Other trademarks owned by Randox Laboratories Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named RX ALTONA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 11, 2018 | MAB5 | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | — |
| Apr 11, 2018 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Apr 10, 2018 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Mar 29, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 27, 2018 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 27, 2018 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 27, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 8, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 6, 2017 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 6, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 6, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 28, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 31, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 31, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 11, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 29, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 22, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 22, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 22, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 22, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 22, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 16, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 16, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 14, 2016 | ALIE | ASSIGNED TO LIE | — |
| Nov 30, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| May 31, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 31, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 31, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 26, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 18, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 15, 2016 | NWAP | NEW APPLICATION ENTERED | — |